22 §2698-A. Marketing costs (REPEALED)
§2698-A. Marketing costs (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 688, §C8 (AMD). PL 2005, c. 286, §§1,2 (AMD). PL 2011, c. 461, §3 (RP).
22 §2698-B. Actual price disclosure and certification (REPEALED)
§2698-B. Actual price disclosure and certification (REPEALED) SECTION HISTORY PL 2003, c. 667, §1 (NEW). PL 2003, c. 667, §2 (AFF). PL 2005, c. 402, §§1-4 (AMD). PL 2011, c. 461, §4 (RP).
22 §2699. Prescription drug practices (REPEALED)
§2699. Prescription drug practices (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 430, §1 (NEW). PL 2003, c. 430, §3 (AFF). PL 2003, c. 456, §1 (NEW). PL 2003, c. 673, §§FFF1,2 (AMD). PL 2003, c. 688, §§C9,10 (AMD). PL 2003, c. 688, §C11 (AFF). […]
22 §2685. Prescription drug academic detailing program
§2685. Prescription drug academic detailing program By January 1, 2008, the department shall establish a prescription drug academic detailing program, referred to in this section as “the program,” to enhance the health of residents of the State, to improve the quality of decisions regarding drug prescribing, to encourage better communication between the department and health […]
22 §2687. Maximum allowable cost list
§2687. Maximum allowable cost list 1. Comment period. The Department of Health and Human Services, office of MaineCare services shall establish a 17-day written comment period on any proposed change to the state maximum allowable cost list if the change results in a reduction in payment to pharmacies. The written comment period must be held […]
22 §2691. Short title; purpose
§2691. Short title; purpose This subchapter may be known and cited as the “Prescription Drug Price Reduction Act.” The Legislature finds that affordability is critical in providing access to prescription drugs for Maine residents. This subchapter is enacted by the Legislature as a positive measure to make prescription drugs more affordable for qualified Maine residents, […]
22 §2692. Prescription Drug Advisory Commission (REPEALED)
§2692. Prescription Drug Advisory Commission (REPEALED) SECTION HISTORY PL 1999, c. 786, §A3 (NEW). PL 2007, c. 395, §25 (RP).
22 §2693. Emergency drug pricing
§2693. Emergency drug pricing In order to achieve the public health purposes listed in section 2691, maximum retail prices for prescription drugs sold in Maine may be established pursuant to this section. [PL 1999, c. 786, Pt. A, §3 (NEW).] 1. Emergency drug pricing procedures. The following provisions apply to determinations regarding maximum retail […]
22 §2694. Rulemaking
§2694. Rulemaking With the exception of rules designated in this subchapter as major substantive rules, rules adopted pursuant to this subchapter are routine technical rules as defined by Title 5, chapter 375, subchapter II‑A. [PL 1999, c. 786, Pt. A, §3 (NEW).] SECTION HISTORY PL 1999, c. 786, §A3 (NEW).
22 §2697. Profiteering in prescription drugs
§2697. Profiteering in prescription drugs Prescription drugs are a necessity of life. Profiteering in prescription drugs is unlawful and is subject to the provisions of this section. The provisions of this section apply to manufacturers, distributors and labelers of prescription drugs. [PL 1999, c. 786, Pt. A, §3 (NEW).] 1. Definitions. As used in […]